Differences

This shows you the differences between two versions of the page.

--- pharmaceutical_companies:janssen [2022/01/18 10:32]
liam [COVID-19]
+++ pharmaceutical_companies:janssen [2023/06/04 20:28] (current)
liam
@@ Line 6: / Line 6: @@
 ===== COVID-19 =====
+Janssen is part of the [[:COVID-19 Therapeutics Accelerator]] funded by the [[:Bill & Melinda Gates Foundation]], [[:Wellcome Trust]], and [[:Mastercard]] to “accelerate treatments, vaccines, and diagnostics”.((//Global pharma industry unites behind COVID-19 Therapeutics Accelerator.// (2020, March 26). The Pharma Letter. https://archive.ph/5RTn4))
 ==== Ad26.COV2.S Vaccine ====
-Janssen is distributing a recombinant "non replicating viral vector" [[:COVID-19 vaccines|COVID-19 vaccine]] product in the United States and other countries worldwide.((//Janssen (Johnson & Johnson): Ad26.COV2.S.// COVID-19 Vaccine Tracker. Retrieved January 18, 2022, from https://archive.ph/nPhNi)) ((National Center for Immunization and Respiratory Diseases. (2021, November 4). //Administration Overview for Johnson & Johnson’s Janssen COVID-19 Vaccine.// U.S. Centers for Disease Control and Prevention (CDC). Retrieved December 5, 2021, from https://archive.ph/svpaI)) It is approved but not widely distributed in Canada.((Health Canada. (2021, March 5). //Janssen COVID-19 Vaccine.// Government of Canada. Retrieved December 5, 2021, from https://covid-vaccine.canada.ca/janssen-covid-19-vaccine/product-details))
+Janssen is distributing a recombinant "non replicating viral vector" [[:COVID-19 vaccines|COVID-19 vaccine]] product in the United States and other countries worldwide.((//Janssen (Johnson & Johnson): Ad26.COV2.S.// COVID-19 Vaccine Tracker. Retrieved January 18, 2022, from https://archive.ph/nPhNi)) ((National Center for Immunization and Respiratory Diseases. (2021, November 4). //Administration Overview for Johnson & Johnson’s Janssen COVID-19 Vaccine.// U.S. Centers for Disease Control and Prevention (CDC). Retrieved December 5, 2021, from https://archive.ph/svpaI)) It is approved but not widely distributed in Canada.((Health Canada. (2021, March 5). //Janssen COVID-19 Vaccine.// Government of Canada. Retrieved December 5, 2021, from https://archive.ph/2cl9Z))
+On June 1, 2023, the [[:Food and Drug Administration]] revoked the EUA for Janssen's product.((Marks, P. (2023, June 1). //Re: Revocation of EUA 27205 - Janssen COVID-19 Vaccine.// Food and Drug Administration. https://web.archive.org/web/20230603070204/https://www.fda.gov/media/169003/download))
+===== Payments from Janssen =====
+The following is a developing list of individuals and organizations that Janssen has given money to related to the COVID-19 pandemic. People and groups included on this list are relevant due to positions of authority or influence in the crisis, and are of note in considering how Janssen and/or [[Johnson & Johnson]] may have manipulated the COVID-19 response through a payment network. Inclusion on this list does not constitute an accusation of wrongdoing without substantiating evidence.
+==== Payments to Organizations ====
+^ Name  ^ Type  ^ Amount  ^ Description ^
+| [[:SickKids]]  | Donation  | $100,000.00 - $999,999.00  | Donations to the SickKids Foundation.((//Annual Report 2020-2021.// (2021). SickKids. https://www.sickkids.ca/siteassets/about/about-sickkids/sickkids-annual-report-2020-2021.pdf))  |
+| [[:University Hospitals Kingston Foundation]]  | Donation  | $50,000.00 – $99,999.00  | Cumulative donations up to December 31, 2019.((//Recognizing your contribution.// University Hospitals Kingston Foundation. Retrieved February 21, 2022, from https://www.uhkf.ca/Your-Impact/Recognizing-Your-Contribution))  |
+{{tag>Pharmaceutical_Companies}}